California Pizza Recall as FDA Issues Highest Risk Warning
What and soy are two of nine major allergens. Others are milk, eggs, sesame, fish, tree nuts, crustacean shellfish and ...
What the FDA ban on Red Dye No. 3 means for consumers
For consumers, the ban on Red No. 3 represents a small victory for public health and safety. It shows that the FDA is ...
Why is the FDA slow to ban food additives?
Red Dye No. 3 is a "color additive made from petroleum," which "could previously be used in foods in small amounts as ...
Federal regulations paused, halting FDA's proposed ban on formaldehyde in hair products
Over the years, an increasing number of studies have linked formaldehyde to cancers that are especially prevalent among Black ...
FDA Changes Food Safety Protocol for Fresh and Frozen Berries
The FDA just announced changes to help make berries sold in the U.S. safer to eat, lowering the odds you’ll get norovirus or ...
Health on MSN6d
FDA Bans Red Dye No. 3 in Food—Over 30 Years After It Was Linked to Cancer in Rats
The FDA has banned red dye No. 3 in food and ingested drugs, the agency announced. But what exactly is red dye No. 3, and why ...
Milk Recall Update As FDA Sets Risk Class Over Spoilage Fears
19,688 cases of the milk overall were recalled, 8,654 of which had an expiry date of 3/3/2025, 7,385 with expiry date 3/4/2025, 1,781 with expiry date 3/6/2025, and 1,868 with expiry date 3/7/2025.
Prop. 36 drug and theft felonies to force millions in state cuts, projection shows
A new spending plan from the governor’s office for the upcoming fiscal year projects a relatively minimal impact to services ...
FDA bans Red No. 3 used in California food and drinks. What is it?
Manufacturers must stop using Red No. 3 in food and reformulate it by Jan. 15, 2027, according to the FDA announcement. The use of dye in drugs will have until Jan. 18, 2028, according to the FDA.
What to know about Medicare in California
California has various Medicare options, including Original Medicare, Medicare Advantage, and Medigap. Learn more here.
US FDA puts clinical hold on Atara's trials for cancer cell therapies
Atara Biotherapeutics said on Tuesday the U.S. health regulator has placed a clinical hold on its trials for cancer cell therapies, sending the drug developer's shares down more than 4% in premarket ...